Loading...
HIV Preexposure Prophylaxis: New Data and Potential Use
HIV preexposure prophylaxis (PrEP) has demonstrated efficacy in 4 studies: 1) the CAPRISA 004 trial of pericoital administration of 1% tenofovir gel showed moderate (39%) efficacy in reducing risk of HIV acquisition in young women; 2) the iPrEx trial of daily oral emtricitabine/tenofovir had moderat...
Na minha lista:
| Udgivet i: | Top Antivir Med |
|---|---|
| Hovedforfatter: | |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
IAS-USA
2016
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6148898/ https://ncbi.nlm.nih.gov/pubmed/22298887 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|